专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20090233993A1 COMPOSITIONS AND METHODS FOR INHIBITING GSK3 ACTIVITY AND USES THEREOF 审中-公开
标题翻译：用于抑制GSK3活性的组合物和方法及其用途
公开(公告)号：US20090233993A1
公开(公告)日：2009-09-17
申请号：US12399850
申请日：2009-03-06
申请人： Huaxi Xu , Limin Li , Francesca-Fang Liao , Yun-wu Zhang , Wu-bo Li , Paul Greengard , Stanley N. Cohen
发明人： Huaxi Xu , Limin Li , Francesca-Fang Liao , Yun-wu Zhang , Wu-bo Li , Paul Greengard , Stanley N. Cohen
IPC分类号： A61K31/7088 , C07H21/00 , C12N15/74 , C12P21/02 , C07K2/00 , C12N5/06 , A61P25/28 , G01N33/567
CPC分类号： C07K14/705 , A61K38/00 , G01N2333/91205 , G01N2800/2821
摘要： Disclosed herein are compositions and methods relating to peptides. The peptides can inhibit amyloid beta (Aβ) generation and reduce GSK-3 activities. Further provided are compositions and methods for treating or preventing, for example, Alzheimer's disease, cancer, and diabetes.
摘要翻译：本文公开了与肽相关的组合物和方法。肽可以抑制淀粉样蛋白β（Abeta）的产生并降低GSK-3活性。还提供了用于治疗或预防例如阿尔茨海默病，癌症和糖尿病的组合物和方法。

2. 发明授权

US08404807B2 Mammalian tumor susceptibility genes and their uses 失效
公开(公告)号：US08404807B2
公开(公告)日：2013-03-26
申请号：US13116911
申请日：2011-05-26
申请人： Stanley N. Cohen , Limin Li
发明人： Stanley N. Cohen , Limin Li
IPC分类号： C07K16/00 , C07K14/00
CPC分类号： G01N33/57415 , C07K14/4702 , C12N15/00 , C12Q1/68 , C12Q1/6886 , C12Q2600/118 , C12Q2600/136
摘要： TSG101 is a tumor susceptibility gene whose homozygous functional knock out in fibroblasts leads to transformation and the ability of these cells to form metastatic tumors in nude mice. The cellular transformation that results from inactivation of TSG101 is reversible by restoration of TSG101 function. Decreased expression of TSG101 is associated with the occurrence of certain human cancers, including breast carcinomas. The TSG101 nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.

3. 发明申请

US20110251376A1 Mammalian Tumor Susceptibility Genes and their Uses 失效
标题翻译：哺乳动物肿瘤易感基因及其用途
公开(公告)号：US20110251376A1
公开(公告)日：2011-10-13
申请号：US13116911
申请日：2011-05-26
申请人： Stanley N. Cohen , Limin Li
发明人： Stanley N. Cohen , Limin Li
IPC分类号： C07K19/00 , C07K16/18
CPC分类号： G01N33/57415 , C07K14/4702 , C12N15/00 , C12Q1/68 , C12Q1/6886 , C12Q2600/118 , C12Q2600/136
摘要： TSG101 is a tumor susceptibility gene whose homozygous functional knock out in fibroblasts leads to transformation and the ability of these cells to form metastatic tumors in nude mice. The cellular transformation that results from inactivation of TSG101 is reversible by restoration of TSG101 function. Decreased expression of TSG101 is associated with the occurrence of certain human cancers, including breast carcinomas. The TSG101 nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.
摘要翻译： TSG101是一种肿瘤易感基因，其纯合功能敲除成纤维细胞导致转化和这些细胞在裸鼠中形成转移性肿瘤的能力。由TSG101失活引起的细胞转化可通过恢复TSG101功能而逆转。 TSG101的表达降低与某些人类癌症（包括乳腺癌）的发生有关。 TSG101核酸组合物用于鉴定同源或相关蛋白质和编码此类蛋白质的DNA序列; 在制备调节蛋白质的表达或功能的组合物中; 并研究相关的生理学途径。此外，体内基因活性的调节用于预防和治疗目的，例如癌症的治疗，基于表达的细胞类型的鉴别等。该DNA进一步用于诊断癌症的遗传易感性，并鉴定具有该基因突变的特异性癌症。

4. 发明申请

US20100272728A1 MAMMALIAN TUMOR SUSCEPTIBILITY GENE PRODUCTS AND THEIR USES 审中-公开
标题翻译： MAMMALIAN肿瘤基因产物及其用途
公开(公告)号：US20100272728A1
公开(公告)日：2010-10-28
申请号：US12721583
申请日：2010-03-11
申请人： Limin Li , Stanley N. Cohen
发明人： Limin Li , Stanley N. Cohen
IPC分类号： A61K39/395 , A61P35/00
CPC分类号： C07K14/47 , C07K16/18
摘要： The present invention provides methods and compositions for regulating ubiquitination in a cell. In particular, the present invention provides purified polypeptides comprising an ubiquitination-regulating domain. The invention also provides methods of using such polypeptides for screening for agents, for producing antibodies, and for treatment of diseases, e.g., proliferative diseases, neurodegenerative diseases, autoimmune diseases, metabolic disease and developmental abnormalities. The invention further provides antibodies that bind an ubiquitination-regulating domain and agents and antibodies that regulate ubiquitination in cells, e.g., by modulating the interaction between a TSG101 protein and an MDM2 protein.
摘要翻译：本发明提供用于调节细胞中泛素化的方法和组合物。特别地，本发明提供了包含泛素调节结构域的纯化多肽。本发明还提供了使用这种多肽筛选试剂，产生抗体和治疗疾病如增殖性疾病，神经变性疾病，自身免疫性疾病，代谢疾病和发育异常的方法。本发明还提供结合泛素调节结构域的抗体以及调节细胞中的泛素化的试剂和抗体，例如通过调节TSG101蛋白和MDM2蛋白之间的相互作用。

5. 发明授权

US06835816B2 Mammalian tumor susceptibility genes and their uses 失效
标题翻译：哺乳动物肿瘤易感基因及其用途
公开(公告)号：US06835816B2
公开(公告)日：2004-12-28
申请号：US09804690
申请日：2001-03-12
申请人： Stanley N. Cohen , Limin Li
发明人： Stanley N. Cohen , Limin Li
IPC分类号： C07K1600
CPC分类号： G01N33/57415 , C07K14/4702 , C12N15/00 , C12Q1/68 , C12Q1/6886 , C12Q2600/118 , C12Q2600/136
摘要： TSG101 is a tumor susceptibility gene whose homozygous functional knock out in fibroblasts leads to transformation and the ability of these cells to form metastatic tumors in nude mice. The cellular transformation that results from inactivation of TSG101 is reversible by restoration of TSG101 function. Decreased expression of TSG101 is associated with the occurrence of certain human cancers, including breast carcinomas. The TSG101 nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.
摘要翻译： TSG101是一种肿瘤易感基因，其纯合功能敲除成纤维细胞导致转化和这些细胞在裸鼠中形成转移性肿瘤的能力。由TSG101失活引起的细胞转化可通过恢复TSG101功能而逆转。 TSG101的表达降低与某些人类癌症（包括乳腺癌）的发生有关。 TSG101核酸组合物用于鉴定同源或相关蛋白质和编码此类蛋白质的DNA序列; 在制备调节蛋白质的表达或功能的组合物中; 并研究相关的生理学途径。此外，体内基因活性的调节用于预防和治疗目的，例如癌症的治疗，基于表达的细胞类型的鉴别等。该DNA进一步用于诊断癌症的遗传易感性，并鉴定具有该基因突变的特异性癌症。

6. 发明授权

US06248523B1 Mammalian tumor susceptibility genes and their uses 失效
标题翻译：哺乳动物肿瘤易感基因及其用途
公开(公告)号：US06248523B1
公开(公告)日：2001-06-19
申请号：US09146187
申请日：1998-09-01
申请人： Stanley N. Cohen , Limin Li
发明人： Stanley N. Cohen , Limin Li
IPC分类号： C12Q168
CPC分类号： G01N33/57415 , C07K14/4702 , C12N15/00 , C12Q1/68 , C12Q1/6886 , C12Q2600/118 , C12Q2600/136
摘要： TSG101 is a tumor susceptibility gene whose homozygous functional knock out in fibroblasts leads to transformation and the ability of these cells to form metastatic tumors in nude mice. The cellular transformation that results from inactivation of TSG101 is reversible by restoration of TSG101 function. Decreased expression of TSG101 is associated with the occurrence of certain human cancers, including breast carcinomas. The TSG101 nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.
摘要翻译： TSG101是一种肿瘤易感基因，其纯合功能敲除成纤维细胞导致转化和这些细胞在裸鼠中形成转移性肿瘤的能力。由TSG101失活引起的细胞转化可通过恢复TSG101功能而逆转。 TSG101的表达降低与某些人类癌症（包括乳腺癌）的发生有关。 TSG101核酸组合物用于鉴定同源或相关蛋白质和编码此类蛋白质的DNA序列; 在制备调节蛋白质的表达或功能的组合物中; 并研究相关的生理学途径。此外，体内基因活性的调节用于预防和治疗目的，例如癌症的治疗，基于表达的细胞类型的鉴别等。该DNA进一步用于诊断癌症的遗传易感性，并鉴定具有该基因突变的特异性癌症。

7. 发明授权

US5891668A Mammalian tumor susceptibility genes and their uses 失效
公开(公告)号：US5891668A
公开(公告)日：1999-04-06
申请号：US670274
申请日：1996-06-13
申请人： Limin Li , Stanley N. Cohen
发明人： Limin Li , Stanley N. Cohen
IPC分类号： C07K14/47 , C12N15/00 , C12Q1/68 , C12P21/02 , C12N15/12
CPC分类号： C12N15/00 , C07K14/4702 , C12Q1/68
摘要： TSG101 is a tumor susceptibility gene whose homozygous functional knock out in fibroblasts leads to transformation and the ability of these cells to form metastatic tumors in nude mice. The cellular transformation that results from inactivation of TSG101 is reversible by restoration of TSG101 function. Decreased expression of TSG101 is associated with the occurrence of certain human cancers, including breast carcinomas. The TSG101 nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.

8. 发明申请

US20100272729A1 MAMMALIAN TUMOR SUSCEPTIBILITY GENE PRODUCTS AND THEIR USES 审中-公开
公开(公告)号：US20100272729A1
公开(公告)日：2010-10-28
申请号：US12721584
申请日：2010-03-11
申请人： LIMIN LI , Stanley N. Cohen
发明人： LIMIN LI , Stanley N. Cohen
IPC分类号： A61K39/395 , C07K16/18 , A61P35/00
CPC分类号： C07K14/47 , C07K16/18
摘要： The present invention provides methods and compositions for regulating ubiquitination in a cell. In particular, the present invention provides purified polypeptides comprising an ubiquitination-regulating domain. The invention also provides methods of using such polypeptides for screening for agents, for producing antibodies, and for treatment of diseases, e.g., proliferative diseases, neurodegenerative diseases, autoimmune diseases, metabolic disease and developmental abnormalities. The invention further provides antibodies that bind an ubiquitination-regulating domain and agents and antibodies that regulate ubiquitination in cells, e.g., by modulating the interaction between a TSG101 protein and an MDM2 protein.

9. 发明授权

US5679523A Method for concurrent disruption of expression of multiple alleles of mammalian genes 失效
标题翻译：同时破坏哺乳动物基因多重等位基因表达的方法
公开(公告)号：US5679523A
公开(公告)日：1997-10-21
申请号：US585758
申请日：1996-01-16
申请人： Limin Li , Stanley N. Cohen
发明人： Limin Li , Stanley N. Cohen
IPC分类号： C07K14/47 , C12N15/00 , C12Q1/68 , C07H21/04
CPC分类号： C12Q1/68 , C07K14/4702 , C12N15/00
摘要： Methods are provided for identifying a gene at a random chromosomal locus in the genome of a mammalian cell. The method involves inactivating one copy of the gene by integrating one DNA construct (knockout construct) in that gene copy. The knockout construct includes a positive selection marker region sequence and, in a 5' direction from the selection marker region sequence, a transcription initiation region sequence responsive to a transactivation factor, said transcription initiation region oriented for antisense RNA transcription in the direction away from the selection marker region sequence. The second copy of the gene is inactivated by transforming the cells with a second DNA construct (transactivation construct) containing a gene sequence for the transactivation factor which initiates antisense RNA transcription extending from the knockout construct into the chromosomal locus flanking the knockout construct at its 5' end. Inactivation of both gene copies may result in a change in cell phenotype distinguishable from the wild-type phenotype. Optionally, the wild-type phenotype can be regained by introducing a third construct that can inhibit antisense RNA transcription.
摘要翻译：提供了用于鉴定哺乳动物细胞基因组中随机染色体基因座上的基因的方法。该方法包括通过在该基因拷贝中整合一个DNA构建体（敲除构建体）来使基因的一个拷贝失活。敲除构建体包括阳性选择标记区序列，并且在从选择标记区序列的5'方向上，对反式激活因子有反应的转录起始区序列，所述转录起始区取向为远离选择标记区序列。通过用包含反式激活因子的基因序列的第二个DNA构建体（反式激活构建体）转化细胞来灭活该基因的第二个拷贝，其启动从敲除构建体延伸到其敲除构建体侧翼的染色体基因座的5' ' 结束。两种基因拷贝的失活可导致与野生型表型区分开的细胞表型的变化。任选地，可以通过引入可抑制反义RNA转录的第三构建体来恢复野生型表型。

10. 发明授权

US07973130B2 Mammalian tumor susceptibility genes and their uses 失效
标题翻译：哺乳动物肿瘤易感基因及其用途
公开(公告)号：US07973130B2
公开(公告)日：2011-07-05
申请号：US10697720
申请日：2003-10-29
申请人： Stanley N. Cohen , Limin Li
发明人： Stanley N. Cohen , Limin Li
IPC分类号： C07K14/435
CPC分类号： G01N33/57415 , C07K14/4702 , C12N15/00 , C12Q1/68 , C12Q1/6886 , C12Q2600/118 , C12Q2600/136
摘要： TSG101 is a tumor susceptibility gene whose homozygous functional knock out in fibroblasts leads to transformation and the ability of these cells to form metastatic tumors in nude mice. The cellular transformation that results from inactivation of TSG101 is reversible by restoration of TSG101 function. Decreased expression of TSG101 is associated with the occurrence of certain human cancers, including breast carcinomas. The TSG101 nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.
摘要翻译： TSG101是一种肿瘤易感基因，其纯合功能敲除成纤维细胞导致转化和这些细胞在裸鼠中形成转移性肿瘤的能力。由TSG101失活引起的细胞转化可通过恢复TSG101功能而逆转。 TSG101的表达降低与某些人类癌症（包括乳腺癌）的发生有关。 TSG101核酸组合物用于鉴定同源或相关蛋白质和编码此类蛋白质的DNA序列; 在制备调节蛋白质的表达或功能的组合物中; 并研究相关的生理学途径。此外，体内基因活性的调节用于预防和治疗目的，例如癌症的治疗，基于表达的细胞类型的鉴别等。该DNA进一步用于诊断癌症的遗传易感性，并鉴定具有该基因突变的特异性癌症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式